Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats
Background: The therapeutic use of Kampo medicine, Sho-seiryu-to (SST) in allergic disorders is well known. As histamine plays a central role in allergic diseases, it is possible that SST affects the allergy-related histamine signaling. In this study, we investigated the effect of SST on allergy-rel...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015306651 |
id |
doaj-bea322a2edaa447593a6bd248d872cd4 |
---|---|
record_format |
Article |
spelling |
doaj-bea322a2edaa447593a6bd248d872cd42020-11-24T23:04:23ZengElsevierAllergology International1323-89302009-01-01581818810.2332/allergolint.O-07-526Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model RatsAsish Kumar Das0Hiroyuki Mizuguchi1Madoka Kodama2Shrabanti Dev3Hayato Umehara4Yoshiaki Kitamura5Chiyo Matsushita6Noriaki Takeda7Hiroyuki Fukui8Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Otolaryngology, Institute of Health-Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Otolaryngology, Institute of Health-Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Background: The therapeutic use of Kampo medicine, Sho-seiryu-to (SST) in allergic disorders is well known. As histamine plays a central role in allergic diseases, it is possible that SST affects the allergy-related histamine signaling. In this study, we investigated the effect of SST on allergy-related histamine signaling in the nasal mucosa of toluene 2, 4-diisocyanate (TDI)-sensitized nasal allergy model rats. Methods: Six-week-old male, Brown Norway rats were sensitized for 2 weeks with 10 μl of 10% TDI, and after a 1 week interval, provocation was initiated with the same amount of TDI. SST (0.6 g/rat) was given orally 1 hour before TDI treatment began for a period of 3 weeks. Nasal symptoms were scored for 10 minutes immediately after TDI-provocation. The genes expression in nasal mucosa was determined using real-time quantitative RT-PCR. Results: SST significantly suppressed TDI-induced nasal allergy-like symptoms. TDI provocation showed a significant up-regulation of histamine H1 receptor (H1R) and histidine decarboxylase (HDC) gene expressions. Prolonged pre-treatment of SST significantly suppressed the mRNA levels of H1R and HDC that was up-regulated by TDI. SST also suppressed TDI-induced interleukin (IL)-4 and IL-5 mRNA elevation. However, SST showed no significant effect for TDI-induced mRNA elevation of IL-13. Conclusions: These results demonstrate that SST alleviates nasal symptoms by the inhibition of histamine signaling through suppression of TDI-induced H1R and HDC gene up-regulation. SST also suppresses cytokine signaling through suppression of IL-4 and IL-5 gene expression. Suppression of histamine signaling may be a novel mechanism of SST in preventing allergic diseases.http://www.sciencedirect.com/science/article/pii/S1323893015306651allergygene expressionhistamine H1 receptorshistamine signalinghistidine decarboxylaseTh2 cytokines |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Asish Kumar Das Hiroyuki Mizuguchi Madoka Kodama Shrabanti Dev Hayato Umehara Yoshiaki Kitamura Chiyo Matsushita Noriaki Takeda Hiroyuki Fukui |
spellingShingle |
Asish Kumar Das Hiroyuki Mizuguchi Madoka Kodama Shrabanti Dev Hayato Umehara Yoshiaki Kitamura Chiyo Matsushita Noriaki Takeda Hiroyuki Fukui Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats Allergology International allergy gene expression histamine H1 receptors histamine signaling histidine decarboxylase Th2 cytokines |
author_facet |
Asish Kumar Das Hiroyuki Mizuguchi Madoka Kodama Shrabanti Dev Hayato Umehara Yoshiaki Kitamura Chiyo Matsushita Noriaki Takeda Hiroyuki Fukui |
author_sort |
Asish Kumar Das |
title |
Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats |
title_short |
Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats |
title_full |
Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats |
title_fullStr |
Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats |
title_full_unstemmed |
Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats |
title_sort |
sho-seiryu-to suppresses histamine signaling at the transcriptional level in tdi-sensitized nasal allergy model rats |
publisher |
Elsevier |
series |
Allergology International |
issn |
1323-8930 |
publishDate |
2009-01-01 |
description |
Background: The therapeutic use of Kampo medicine, Sho-seiryu-to (SST) in allergic disorders is well known. As histamine plays a central role in allergic diseases, it is possible that SST affects the allergy-related histamine signaling. In this study, we investigated the effect of SST on allergy-related histamine signaling in the nasal mucosa of toluene 2, 4-diisocyanate (TDI)-sensitized nasal allergy model rats.
Methods: Six-week-old male, Brown Norway rats were sensitized for 2 weeks with 10 μl of 10% TDI, and after a 1 week interval, provocation was initiated with the same amount of TDI. SST (0.6 g/rat) was given orally 1 hour before TDI treatment began for a period of 3 weeks. Nasal symptoms were scored for 10 minutes immediately after TDI-provocation. The genes expression in nasal mucosa was determined using real-time quantitative RT-PCR.
Results: SST significantly suppressed TDI-induced nasal allergy-like symptoms. TDI provocation showed a significant up-regulation of histamine H1 receptor (H1R) and histidine decarboxylase (HDC) gene expressions. Prolonged pre-treatment of SST significantly suppressed the mRNA levels of H1R and HDC that was up-regulated by TDI. SST also suppressed TDI-induced interleukin (IL)-4 and IL-5 mRNA elevation. However, SST showed no significant effect for TDI-induced mRNA elevation of IL-13.
Conclusions: These results demonstrate that SST alleviates nasal symptoms by the inhibition of histamine signaling through suppression of TDI-induced H1R and HDC gene up-regulation. SST also suppresses cytokine signaling through suppression of IL-4 and IL-5 gene expression. Suppression of histamine signaling may be a novel mechanism of SST in preventing allergic diseases. |
topic |
allergy gene expression histamine H1 receptors histamine signaling histidine decarboxylase Th2 cytokines |
url |
http://www.sciencedirect.com/science/article/pii/S1323893015306651 |
work_keys_str_mv |
AT asishkumardas shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats AT hiroyukimizuguchi shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats AT madokakodama shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats AT shrabantidev shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats AT hayatoumehara shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats AT yoshiakikitamura shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats AT chiyomatsushita shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats AT noriakitakeda shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats AT hiroyukifukui shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats |
_version_ |
1725630788644372480 |